MacroGenics Ownership | Who Owns MacroGenics?

Overview Forecast RevenueFinancials Chart Transcripts

MacroGenics Ownership Summary

MacroGenics is owned by 76.57% institutional investors, 3.09% insiders, and 20.34% retail investors. Bellevue group is the largest institutional shareholder, holding 15.75% of MGNX shares. BB Biotech AG Ord is the top mutual fund, with 15.82% of its assets in MacroGenics shares.

MGNX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	MacroGenics	76.57%	3.09%	20.34%
Sector	Healthcare Stocks	488.17%	11.08%	-399.26%
Industry	Biotech Stocks	306.59%	11.10%	-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bellevue group	9.92M	15.75%	$12.00M
Armistice capital	5.96M	9.47%	$7.21M
Blackrock	5.40M	8.67%	$22.96M
Vanguard group	4.32M	6.88%	$14.03M
Wasatch advisors lp	3.25M	5.16%	$3.93M
Frazier life sciences management	3.18M	5.04%	$3.84M
Millennium management	2.86M	4.57%	$9.31M
Acadian asset management	2.49M	3.96%	$3.01M
Blackrock funding, inc. /de	1.82M	2.89%	$2.20M
State street	1.54M	2.48%	$6.56M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bellevue group	9.92M	0.26%	$12.00M
Frazier life sciences management	3.18M	0.15%	$3.84M
Rock springs capital management lp	1.05M	0.13%	$3.42M
Armistice capital	5.96M	0.12%	$7.21M
Wasatch advisors lp	3.25M	0.02%	$3.93M
Ikarian capital	80.07K	0.02%	$96.89K
Vestal point capital, lp	280.00K	0.02%	$338.80K
Tang capital management	218.86K	0.01%	$264.82K
K2 principal fund	14.80K	0.01%	$62.90K
Point72 asia (singapore) pte.	50.21K	0.01%	$60.76K

Top Buyers

Holder	Shares	% Assets	Change
Jacobs levy equity management	418.89K	0.01%	270.87K
Morgan stanley	472.24K	0.00%	260.29K
Jpmorgan chase	546.81K	0.00%	221.91K
Renaissance	538.52K	0.00%	220.10K
Acadian asset management	2.49M	0.01%	183.05K

Top Sellers

Holder	Shares	% Assets	Change
Avoro capital advisors	-	-	-6.15M
Blackrock funding, inc. /de	1.82M	-	-3.10M
State street	1.54M	0.00%	-2.85M
T. rowe price investment management	-	-	-2.77M
Ra capital management	-	-	-2.08M

New Positions

Holder	Shares	% Assets	Change	Value
Bridgeway capital management	104.00K	0.01%	104.00K	$338.00K
Hap trading	75.00K	0.00%	75.00K	$15.00K
Point72 asia (singapore) pte.	50.21K	0.01%	50.21K	$60.76K
Spc financial	37.75K	0.01%	37.75K	$122.69K
Y-intercept (hong kong)	29.95K	0.00%	29.95K	$36.23K

Sold Out

Holder	Change
Financial gravity asset management	-2.00
Pnc financial services group	-12.00
Nelson, van denburg & campbell wealth management group	-13.00
Farther finance advisors	-20.00
Rothschild investment	-55.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	111	-12.60%	48,210,576	-8.42%	76	1.10%	48	-11.11%	34	-15.00%
Mar 31, 2025	127	-1.55%	53,716,987	-4.04%	85	1.07%	55	-11.29%	40	5.26%
Dec 31, 2024	120	-8.40%	51,256,584	-7.97%	81	1.04%	57	5.56%	35	-23.91%
Sep 30, 2024	130	-15.03%	55,695,757	-8.38%	88	0.94%	54	-32.50%	46	-
Jun 30, 2024	152	-10.59%	60,787,295	-6.23%	97	890450.81%	80	-16.67%	45	-8.16%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
BB Biotech AG Ord	9.93M	15.82%	-
Wasatch Ultra Growth	2.82M	4.47%	-
Vanguard US Total Market Shares ETF	2.00M	3.17%	-
Vanguard Total Stock Mkt Idx Inv	1.93M	3.06%	-42.58K
Wasatch Micro Cap	773.76K	1.23%	-
Vanguard Institutional Extnd Mkt Idx Tr	639.64K	1.01%	-291.46K
Fidelity Small Cap Index	633.43K	1.00%	-6.51K
State St Russell Sm/Mid Cp® Indx NL Cl C	476.20K	0.75%	-
State St Russell Sm/Mid Cp® Indx SL Cl I	476.20K	0.75%	-
iShares Russell 2000 Growth ETF	450.86K	0.71%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 19, 2025	HEIDEN WILLIAM K	-	Buy	$76.76K
Aug 20, 2025	HEIDEN WILLIAM K	-	Buy	$73.75K
Feb 15, 2025	Smith Beth Ann	VP, Controller & Treasurer	Sell	$1.08K
Apr 04, 2024	Peters Jeffrey Stuart	Senior VP and General Counsel	Sell	$3.80K
Apr 04, 2024	Peters Jeffrey Stuart	Senior VP and General Counsel	Sell	$2.28K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	2	-
2025 Q2	-	-
2025 Q1	-	1
2024 Q4	-	-
2024 Q3	-	-

MGNX Ownership FAQ

Who Owns MacroGenics?

MacroGenics shareholders are primarily institutional investors at 76.57%, followed by 3.09% insiders and 20.34% retail investors. The average institutional ownership in MacroGenics's industry, Biotech Stocks , is 306.59%, which MacroGenics falls below.

Who owns the most shares of MacroGenics?

MacroGenics’s largest shareholders are Bellevue group (9.92M shares, 15.75%), Armistice capital (5.96M shares, 9.47%), and Blackrock (5.4M shares, 8.67%). Together, they hold 33.89% of MacroGenics’s total shares outstanding.

Does Blackrock own MacroGenics?

Yes, BlackRock owns 8.67% of MacroGenics, totaling 5.4M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 22.96M$. In the last quarter, BlackRock decreased its holdings by -294K shares, a -5.17% change.

Who is MacroGenics’s biggest shareholder by percentage of total assets invested?

Bellevue group is MacroGenics’s biggest shareholder by percentage of total assets invested, with 0.26% of its assets in 9.92M MacroGenics shares, valued at 12M$.

Who is the top mutual fund holder of MacroGenics shares?

BB Biotech AG Ord is the top mutual fund holder of MacroGenics shares, with 15.82% of its total shares outstanding invested in 9.93M MacroGenics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools